9^th World Congress On Cardiology and Heart Failure

Biomarkers in Heart Failure

Biomarkers are crucial for diagnosing, monitoring, and predicting outcomes in heart failure. They complement imaging and clinical evaluation.

Key Highlights:

• Natriuretic peptides: BNP and NT-proBNP indicate heart failure severity.
• Cardiac troponins: Detect ongoing myocardial injury.
• Inflammatory markers: CRP and interleukins reflect systemic inflammation.
• Renal biomarkers: Help detect cardiorenal syndrome.
• Therapeutic monitoring: Biomarkers guide medication titration and therapy response.

Using biomarkers improves early detection, guides personalized therapy, and reduces complications in heart failure management.